Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission

Journal of Neuroimmunology

Volumn 239, Issue 1-2, 2011, Pages 80-86

  Knippenberg, Stephanie ^a,b   Peelen, Evelyn ^a,b   Smolders, Joost ^a,b   Thewissen, Mariëlle ^a   Menheere, Paul ^a   Cohen Tervaert, Jan Willem ^a   Hupperts, Raymond ^a,b   Damoiseaux, Jan ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

Author keywords

B cell; Multiple sclerosis; Regulatory B cell; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CD19 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; IMMUNOGLOBULIN D; INTERLEUKIN 10; VITAMIN D;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; REMISSION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES, REGULATORY; CELLS, CULTURED; FEMALE; G0 PHASE; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOPENIA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; TOLL-LIKE RECEPTOR 9; VITAMIN D;

EID: 80054880898     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.08.019     Document Type: Article

References (34)

1. Agematsu K., Hokibara S., Nagumo H., Komiyama A. CD27: a memory B-cell marker. Immunol. Today 2000, 21:204-206.
2. Bar-Or A., Calabresi P.A., Arnold D., Markowitz C., Shafer S., Kasper L.H., Waubant E., Gazda S., Fox R.J., Panzara M., Sarkar N., Agarwal S., Smith C.H. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann. Neurol. 2008, 63:395-400.
3. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
4. Bouaziz J.D., Calbo S., Maho-Vaillant M., Saussine A., Bagot M., Bensussan A., Musette P. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur. J. Immunol. 2010, 40:2686-2691.
5. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., Sommer N., Hartung H.P., Hemmer B. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005, 128:1667-1676.
6. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Lipsky P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 2007, 179:1634-1647.
7. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
8. Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., Gambini C., Mancardi G.L., Uccelli A., Pistoia V. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:11064-11069.
9. Duddy M.E., Alter A., Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation?. J. Immunol. 2004, 172:3422-3427.
10. Duddy M., Niino M., Adatia F., Hebert S., Freedman M., Atkins H., Kim H.J., Bar-Or A. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 2007, 178:6092-6099.
11. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002, 3:944-950.
12. Harp C.T., Ireland S., Davis L.S., Remington G., Cassidy B., Cravens P.D., Stuve O., Lovett-Racke A.E., Eagar T.N., Greenberg B.M., Racke M.K., Cowell L.G., Karandikar N.J., Frohman E.M., Monson N.L. Memory B cells from a subset of treatment-naive relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-gamma production in response to myelin basic protein and myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 2010, 40:2942-2956.
13. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
14. Heine G., Niesner U., Chang H.D., Steinmeyer A., Zugel U., Zuberbier T., Radbruch A., Worm M. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur. J. Immunol. 2008, 38:2210-2218.
15. Hirotani M., Niino M., Fukazawa T., Kikuchi S., Yabe I., Hamada S., Tajima Y., Sasaki H. Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis. J. Neuroimmunol. 2010, 221:95-100.
16. Holmoy T., Lossius A., Gundersen T.E., Moen S.M., Castellazzi M., Fainardi E., Casetta I. Intrathecal levels of vitamin D and IgG in multiple sclerosis. Acta Neurol. Scand. 2011, doi:10.1111/J1600-0404.2011.01577.x.
17. Knippenberg S., Smolders J., Thewissen M., Peelen E., Tervaert J.W., Hupperts R., Damoiseaux J. Effect of vitamin D3supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis. Mult. Scler. 2011, doi:10.1177/1352458511412655.
18. Krumbholz M., Meinl I., Kumpfel T., Hohlfeld R., Meinl E. Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 2008, 71:1350-1354.
19. Lee-Chang C., Zephir H., Top I., Dubucquoi S., Trauet J., Prin L., Vermersch P. B-cell subsets up-regulate alpha4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset. Neurosci. Lett. 2011, 487:273-277.
20. Lemoine S., Morva A., Youinou P., Jamin C. Human T cells induce their own regulation through activation of B cells. J. Autoimmun. 2011, 36:228-238.
21. Luning Prak E.T., Ross J., Sutter J., Sullivan K.E. Age-related trends in pediatric B-cell subsets. Pediatr. Dev. Pathol. 2011, 14:45-52.
22. Nashold F.E., Hoag K.A., Goverman J., Hayes C.E. Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2001, 119:16-29.
23. Niino M., Hirotani M., Miyazaki Y., Sasaki H. Memory and naive B-cell subsets in patients with multiple sclerosis. Neurosci. Lett. 2009, 464:74-78.
24. Pascual V., Liu Y.J., Magalski A., de Bouteiller O., Banchereau J., Capra J.D. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 1994, 180:329-339.
25. Putzki N., Baranwal M.K., Tettenborn B., Limmroth V., Kreuzfelder E. Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells. Eur. Neurol. 2010, 63:311-317.
26. Ramgolam V.S., Sha Y., Marcus K.L., Choudhary N., Troiani L., Chopra M., Markovic-Plese S. B cells as a therapeutic target for IFN-{beta} in relapsing-remitting multiple sclerosis. J. Immunol. 2011, 186:4518-4526.
27. Rieger A., Bar-Or A. B-cell-derived interleukin-10 in autoimmune disease: regulating the regulators. Nat. Rev. Immunol. 2008, 8:486-487.
28. Smolders J., Menheere P., Kessels A., Damoiseaux J., Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult. Scler. 2008, 14:1220-1224.
29. Smolders J., Thewissen M., Peelen E., Menheere P., Tervaert J.W., Damoiseaux J., Hupperts R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009, 4:e6635.
30. Smolders J., Peelen E., Thewissen M., Cohen Tervaert J.W., Menheere P., Hupperts R., Damoiseaux J. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS One 2010, 5:e15235.
31. Spach K.M., Nashold F.E., Dittel B.N., Hayes C.E. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:6030-6037.
32. van de Veerdonk F.L., Lauwerys B., Marijnissen R.J., Timmermans K., Di Padova F., Koenders M.I., Gutierrez-Roelens I., Durez P., Netea M.G., van der Meer J.W., van den Berg W.B., Joosten L.A. The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum. 2011, 63:1507-1516.
33. van der Mei I.A., Ponsonby A.L., Dwyer T., Blizzard L., Taylor B.V., Kilpatrick T., Butzkueven H., McMichael A.J. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J. Neurol. 2007, 254:581-590.
34. Vogt M.H., ten Kate J., Drent R.J., Polman C.H., Hupperts R. Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers. Mult. Scler. 2010, 16:443-449.